UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-03 | Future report Set alerts | |
| Q2 2022 | 2022-08-05 | -0.61 | -0.61 |
| Q1 2022 | 2022-05-06 | -0.62 | -0.62 |
| Q4 2021 | 2022-02-25 | 0.05 | 0.05 |
| Q3 2021 | 2021-11-05 | -0.65 | -0.65 |
| Q2 2021 | 2021-08-06 | -1.19 | -1.19 |
| Q1 2021 | 2021-05-07 | -1.75 | -1.75 |
| Q4 2020 | 2021-02-26 | -2.03 | -2.03 |
| Q3 2020 | 2020-11-05 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-04 | -1.45 | -1.45 |
| 2016-07-10 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-07-07 | Reiterated Rating | Drexel Hamilton | Buy | |
| 2016-06-13 | Initiated Coverage | Credit Suisse | Neutral | $33.00 to $33.00 |
| 2016-06-12 | Reiterated Rating | Credit Suisse | Neutral | $33.00 |
| 2016-06-12 | Reiterated Rating | Credit Suisse Group AG | Neutral | $33.00 |
| 2016-06-10 | Reiterated Rating | Stifel Nicolaus | Buy | |
| 2016-05-15 | Reiterated Rating | B. Riley | Neutral | $41.75 |
| 2016-05-11 | Boost Price Target | Wedbush | Neutral | $36.00 to $40.00 |
| 2016-05-11 | Boost Price Target | FBR & Co. | Outperform | $40.00 to $41.00 |
| 2016-05-11 | Boost Price Target | FBR & Co | Outperform | $40.00 to $41.00 |
| 2016-05-09 | Reiterated Rating | B. Riley | Neutral | $41.75 |
| 2016-05-04 | Reiterated Rating | B. Riley | Neutral | $41.75 |
| 2016-04-25 | Boost Price Target | MKM Partners | Buy | $37.00 to $40.00 |
| 2016-04-06 | Reiterated Rating | Drexel Hamilton | Buy | |
| 2016-04-04 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $37.00 to $40.00 |
| 2016-03-30 | Downgrade | B. Riley | Buy to Neutral | $46.25 to $41.75 |
| 2016-03-18 | Reiterated Rating | Hanson | Neutral | |
| 2016-03-17 | Downgrade | Moffett Nathanson | Buy to Neutral | |
| 2016-03-03 | Downgrade | Benchmark Co. | Buy to Hold | $42.24 to $35.50 |
| 2016-02-28 | Reiterated Rating | B. Riley | Buy | $42.00 |
| 2016-02-25 | Reiterated Rating | FBR & Co. | Buy | $38.00 |
| 2016-02-24 | Lower Price Target | Topeka Capital Markets | Buy | $44.00 to $43.00 |
| 2016-02-23 | Reiterated Rating | B. Riley | Buy | $43.50 |
| 2016-02-22 | Reiterated Rating | Wedbush | Neutral | $36.00 |
| 2016-02-22 | Lower Price Target | Benchmark Co. | Buy | $49.32 to $42.24 |
| 2016-02-18 | Lower Price Target | Topeka Capital Markets | Buy | $45.00 to $44.00 |
| 2016-02-18 | Reiterated Rating | B. Riley | Buy | $43.50 |
| 2016-02-04 | Downgrade | Credit Suisse | Outperform to Neutral | $37.00 to $33.00 |
| 2016-01-28 | Lower Price Target | MKM Partners | Buy | $43.00 to $37.00 |
| 2016-01-15 | Reiterated Rating | Wedbush | Hold | $36.00 |
| 2016-01-14 | Reiterated Rating | Wunderlich | Buy | $50.00 to $40.00 |
| 2016-01-14 | Initiated Coverage | Drexel Hamilton | Buy | $41.00 |
| 2016-01-12 | Lower Price Target | Topeka Capital Markets | Buy | $46.00 to $45.00 |
| 2016-01-07 | Lower Price Target | JPMorgan Chase & Co. | $42.00 to $39.00 | |
| 2016-01-04 | Lower Price Target | Stifel Nicolaus | Buy | $40.00 to $34.00 |
| 2015-11-12 | Reiterated Rating | B. Riley | Buy | $45.00 |
| 2015-11-07 | Reiterated Rating | B. Riley | Buy | $45.00 |
| 2015-11-02 | Reiterated Rating | B. Riley | Buy | $45.00 |
| 2015-10-15 | Downgrade | Morgan Stanley | Equal Weight to Underweight | $42.00 to $33.00 |
| 2015-10-09 | Lower Price Target | MKM Partners | Buy | $48.00 to $43.00 |
| 2015-10-05 | Lower Price Target | Topeka Capital Markets | Buy | $47.00 to $46.00 |
| 2015-09-28 | Lower Price Target | Stifel Nicolaus | Buy | $46.00 to $40.00 |
| 2015-09-08 | Downgrade | Macquarie | Outperform to Neutral | $46.00 to $42.00 |
| 2015-08-21 | Reiterated Rating | FBR & Co. | Buy | $49.00 to $44.00 |
| 2015-08-12 | Upgrade | B. Riley | Buy | $45.00 |
| 2015-08-10 | Lower Price Target | RBC Capital | Outperform | $54.00 to $50.00 |
| 2015-08-10 | Lower Price Target | Royal Bank Of Canada | Outperform | $54.00 to $50.00 |
| 2015-08-07 | Upgrade | BB&T Corp. | Hold to Buy | $40.50 to $45.00 |
| 2015-08-07 | Upgrade | B. Riley | Neutral to Buy | $40.50 to $45.00 |
| 2015-08-03 | Reiterated Rating | B. Riley | Market Perform to Neutral | $45.00 to $40.50 |
| 2015-07-31 | Reiterated Rating | Wedbush | Neutral | $47.00 |
| 2015-07-22 | Initiated Coverage | Benchmark Co. | Buy | $49.13 |
| 2015-07-21 | Reiterated Rating | MKM Partners | Buy | |
| 2015-06-09 | Upgrade | Topeka Capital Markets | Hold to Buy | $42.00 to $47.00 |
| 2015-05-08 | Lower Price Target | RBC Capital | Outperform | $55.00 to $54.00 |
| 2015-05-07 | Set Price Target | Wedbush | Hold | $47.00 |
| 2015-05-05 | Reiterated Rating | B. Riley | Neutral | $40.50 |
| 2015-04-16 | Initiated Coverage | RBC Capital | Outperform | $55.00 |
| 2015-04-14 | Reiterated Rating | Wedbush | Neutral | $47.00 |
| 2015-04-08 | Downgrade | Janney Montgomery Scott | Buy to Neutral | $44.00 |
| 2015-04-02 | Boost Price Target | Topeka Capital Markets | Hold | $40.00 to $42.00 |
| 2015-02-19 | Reiterated Rating | Wedbush | Neutral | $40.00 |
| 2015-02-19 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $40.00 to $45.00 |
| 2015-02-19 | Boost Price Target | Wunderlich | Buy | $44.00 to $50.00 |
| 2015-02-19 | Set Price Target | FBR & Co. | Buy | $39.00 to $47.00 |
| 2015-02-18 | Set Price Target | Stifel Nicolaus | Buy | $46.00 |
| 2015-02-18 | Boost Price Target | Janney Montgomery Scott | $44.00 | |
| 2015-02-18 | Reiterated Rating | B. Riley | Neutral | $44.50 |
| 2015-02-18 | Boost Price Target | MKM Partners | Buy | $40.00 to $44.00 |
| 2014-11-26 | Downgrade | Topeka Capital Markets | Buy to Hold | $39.00 |
| 2014-09-08 | Boost Price Target | Morgan Stanley | Equal Weight | $34.00 to $36.00 |
| 2014-09-03 | Upgrade | Stifel Nicolaus | Hold to Buy | $42.00 |
| 2014-08-13 | Reiterated Rating | Wunderlich | Buy | $40.00 to $44.00 |
| 2014-07-18 | Boost Price Target | MKM Partners | Buy | $34.00 to $40.00 |
| 2014-07-07 | Downgrade | B. Riley & Co. | Buy to Neutral | |
| 2014-07-07 | Initiated Coverage | Hudson Square Research | Buy | |
| 2014-07-07 | Downgrade | Citigroup Inc. | Buy to Neutral | |
| 2014-07-07 | Downgrade | B. Riley | Buy to Neutral | $36.75 |
| 2014-07-03 | Boost Price Target | Topeka Capital Markets | $39.00 | |
| 2014-06-30 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $34.00 to $39.00 |
| 2014-05-27 | Upgrade | B. Riley | Neutral to Buy | $33.50 to $36.75 |
| 2014-03-18 | Lower Price Target | FBR & Co. | Outperform | $38.00 to $36.00 |
| 2014-02-20 | Lower Price Target | Macquarie | $36.00 to $35.00 | |
| 2014-02-19 | Initiated Coverage | Topeka Capital Markets | Buy | |
| 2014-02-18 | Lower Price Target | MKM Partners | Buy | $38.00 to $34.00 |
| 2014-02-10 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | |
| 2014-01-02 | Boost Price Target | Wunderlich | Buy | $37.00 to $40.00 |
| 2013-11-18 | Boost Price Target | Wedbush | Neutral | $29.00 to $34.00 |
| 2013-11-12 | Upgrade | Janney Montgomery Scott | Neutral to Buy | $37.00 to $46.00 |
| 2013-11-08 | Boost Price Target | MKM Partners | Buy | $36.00 to $38.00 |
| 2013-11-05 | Initiated Coverage | FBR & Co. | Outperform | |
| 2013-11-04 | Initiated Coverage | FBR & Co. | Outperform | |
| 2013-10-14 | Initiated Coverage | Hanson | Buy | $36.00 |
| 2013-10-07 | Boost Price Target | Janney Montgomery Scott | Neutral | $32.00 to $35.00 |
| 2013-08-13 | Reiterated | Wunderlich | Buy | $34 to $37 |
| 2013-07-10 | Initiated | Ascendiant Capital Markets | Buy | $32 |
| 2013-05-03 | Reiterated | MKM Partners | Buy | $31 to $36 |
| 2013-01-15 | Reiterated | MKM Partners | Buy | $30 to $31 |
| 2012-07-18 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2012-05-24 | Initiated | Wunderlich | Buy | $30 |
| 2011-08-11 | Upgrade | Caris & Company | Average to Above Average | |
| 2011-04-11 | Downgrade | Caris & Company | Above Average to Average | |
| 2011-02-25 | Downgrade | Wedbush | Outperform to Neutral | $20 to $20 |
| 2010-08-05 | Reiterated | Wedbush | Outperform | $18 to $20 |
| 2010-07-06 | Upgrade | Caris & Company | Below Average to Average | $14 to $16 |
| 2010-06-22 | Reiterated | Caris & Company | Below Average | $15 to $14 |
| 2016-07-10 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-07-07 | Reiterated Rating | Drexel Hamilton | Buy | |
| 2016-06-13 | Initiated Coverage | Credit Suisse | Neutral | $33.00 to $33.00 |
| 2016-06-12 | Reiterated Rating | Credit Suisse | Neutral | $33.00 |
| 2016-06-12 | Reiterated Rating | Credit Suisse Group AG | Neutral | $33.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CNK 189 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 18.05M |
| Vanguard Group, Inc | 12.41M |
| WELLINGTON MANAGEMENT CO LLP | 11.53M |
| BlackRock Fund Advisors | 6.96M |
| FMR LLC | 4.52M |
| Polaris Capital Management, LLC | 3.86M |
| STATE STREET CORP | 3.74M |
| CITADEL ADVISORS LLC | 3.40M |
| Sentry Select Capital Corp. | 3.30M |
| BlackRock Institutional Trust Company, N.A. | 3.28M |
| Clal Insurance Enterprises Holdings Ltd | 3.07M |
| GOLDMAN SACHS GROUP INC | 2.94M |
| RENAISSANCE TECHNOLOGIES LLC | 2.61M |
| MORGAN STANLEY | 2.16M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.86M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| MITCHELL LEE ROY | 4.67% (5403750) | CNK / TCBI / |
| Stock Alan W Former CEO | 0.29% (338005) | CNK / |
| Zoradi Mark | 0.23% (271216) | CNK / |
| Cavalier Michael SVP-General Counsel | 0.15% (168008) | CNK / |
| Copple Robert Chief Financial Officer | 0.14% (165506) | CNK / |
| Warner Timothy CEO, President and COO | 0.10% (120585) | CNK / |
| Gamble Sean Chief Financial Officer | 0.09% (100141) | CNK / |
| Fernandes Valmir Pr - Cinemark International | 0.08% (96453) | CNK / |
| CHERESKIN BENJAMIN D | 0.05% (55942) | BDBD / CDW / CNK / TUES / |
| SENIOR ENRIQUE | 0.05% (54327) | CNK / |
| Sepulveda Carlos M | 0.05% (54327) | CNK / MTDR / TBK / |
| SODERQUIST DONALD G | 0.04% (51505) | CNK / |
| ROSENBERG STEVE | 0.04% (48216) | CNK / PRGX / TCBI / |
| Owens Tom SVP - Real Estate | 0.04% (43723) | CNK / |
| Bunnell Steve SVP - Film Licensing | 0.04% (42445) | CNK / |
| STAUBACH ROGER T | 0.04% (42325) | AAL / CNK / CONE / JLL / |
| EZERSKY PETER | 0.02% (27518) | CNK / DHX / |
| DOMBALAGIAN VAHE A | 0.02% (17874) | CNK / |
| Syufy Raymond W | 0.01% (15175) | CNK / |
| Humrichouse Ximena G | 0.01% (10219) | CMA / CNK / KSS / |
| Antonellis Darcy | 0.01% (8496) | CNK / |
UM